USPTO grants another CRISPR patent to Charpentier
12-03-2019
EPO grants second CRISPR patent to ERS Genomics
07-03-2018
PTAB says Broad's CRISPR patents do not interfere with UC Berkeley's
16-02-2017
Kieferpix / iStockphoto.com
The US Patent and Trademark Office (USPTO) has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Emmanuelle Charpentier, USPTO, CRISPR-Cas9 patent, genomics research, gene technology
